Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Endocrinology
•
Bone and Calcium Disorders
•
Male and Female Reproductive Disorders
Should estrogen therapy be initiated in patients with refractory functional hypothalamic amenorrhea to improve bone health?
Related Questions
How do you view the efficacy of estrogen replacement therapy in trans-women with regards to osteoporosis prevention and treatment?
Is bilateral oophorectomy the first-line treatment for ovarian hyperthecosis?
How long do you wait before reassessing a 24 hour urine calcium level in patients with recurrent nephrolithiasis, hypercalciuria, and osteoporosis who are initiated on bisphosphonate therapy?
Would you consider anabolic osteoporosis therapy in a young adult male with multiple non-traumatic vertebral compression fractures and low bone density for age (Z-score -2.6)?
Given the better safety profile of transdermal estrogen, is there a specific clinical advantage to using oral estrogen to treat menopausal symptoms?
How do you manage osteoporosis in patients with anorexia nervosa (who often are young women < 40)?
Do you discontinue thiazide treatment used for patients with hypercalciuria and osteoporosis if they develop mild hyponatremia as an adverse effect?
Should testosterone replacement be stopped in elderly men who suffered acute stroke even when testosterone levels have been stably in the low-to-mid normal range?
Which anabolic agent is preferred (teriparatide/abaloparatide versus romosozumab) for osteoporosis treatment in suspected hypophosphatasia?
Would you consider exploratory surgery in a young patient with normocalcemic hyperparathyroidism that meets one or more criteria for parathyroidectomy but has no localized pathology on advanced neck imaging?
